MARKET

OPGN

OPGN

OpGen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.290
-0.070
-2.96%
Opening 11:30 06/24 EDT
OPEN
2.340
PREV CLOSE
2.360
HIGH
2.345
LOW
2.270
VOLUME
222.85K
TURNOVER
--
52 WEEK HIGH
4.440
52 WEEK LOW
1.630
MARKET CAP
87.63M
P/E (TTM)
-1.3264
1D
5D
1M
3M
1Y
5Y
21 Stocks Moving in Monday's Pre-Market Session
Gainers Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V
Benzinga · 3d ago
Oracle, Roblox among premarket losers' pack
Inhibikase Therapeutics IKT -24% after prices stock offering at $3Blue Apron Holdings APRN -19% after announcing share offering.Alfi (ALF) -14%.Clearside Biomedical (CLSD) -10%.TAL Education (TAL) -10%.TDH Holdings (PETZ) -10%.Unique Fabricating (UFAB) -9%...
Seekingalpha · 06/16 12:21
Is OpGen, Inc. (OPGN) A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards OpGen, Inc. (NASDAQ:OPGN) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company b...
Insider Monkey · 06/15 18:14
OpGen gains on insider buying
Makhbubakhon Ismatova/iStock via Getty Images The precision medicine company OpGen ([[OPGN]] +4.2%) appears to be on track to end its three-day losing streak after the company revealed insider transactions by
Seekingalpha · 06/15 15:26
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jun. 15, 2021: LEN, RIOT, CLII, NOVN, OPGN
Today's 5 Stock Ideas Lennar (LEN) - Will report Q2 earnings after market close on Wednesday. Riot Blockchain (RIOT) - Shares were higher Tuesday morning, a sympathy move following news out of peer in
Benzinga · 06/15 12:45
Thinking about buying stock in Ocugen, Rapt Therapeutics, ContextLogic, OpGen, or Clean Energy Fuels?
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCGN, RAPT, WISH, OPGN, and CLNE.
PR Newswire - PRF · 06/15 12:30
Torchlight Energy, Ocugen lead premarket gainers
Clearside Biomedical (CLSD) +52% after positive results from early-stage wet AMD trial.Torchlight Energy Resources (TRCH) +33% after declaring special preferred dividend.Unique Fabricating (UFAB) +29%.Ocugen (OCGN) +20% after securing manufacturing partner...
Seekingalpha · 06/15 12:20
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 06/15 12:17
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OPGN. Analyze the recent business situations of OpGen through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OPGN stock price target is 5.50 with a high estimate of 7.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 43
Institutional Holdings: 2.16M
% Owned: 5.65%
Shares Outstanding: 38.27M
TypeInstitutionsShares
Increased
6
1.20M
New
15
411.46K
Decreased
4
4.10K
Sold Out
4
125.41K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.46%
Pharmaceuticals & Medical Research
+1.01%
Key Executives
Chairman/Director
William Rhodes
President/Chief Executive Officer/Director
Oliver Schacht
Chief Financial Officer/Secretary/IR Contact Officer
Timothy Dec
Chief Operating Officer
Johannes Bacher
Chief Information Officer
Vadim Sapiro
Director
Mario Crovetto
Independent Director
R. Don Elsey
Director
Prabhavathi Fernandes
Independent Director
R. Donald Elsey
No Data
About OPGN
OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.

Webull offers kinds of OpGen Inc stock information, including NASDAQ:OPGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OPGN stock methods without spending real money on the virtual paper trading platform.